FamiCord AG
VTIAF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$54.04M
Close$
$-1.73
155.6% downside
Current Fair Value
155.6% downsideOvervalued by 155.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $54.04 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.36 |
| Beta | 0.58 |
| Outstanding Shares | 17,431,762 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -7.05 |
|---|---|
| PEG | 2.63 |
| Price to Sales | 0.62 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$17.39 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About FamiCord AG
723 employees
CEO: Jakub Julian Baran
VITA 34 AG is dedicated to the collection, processing, and long-term storage of stem cells derived from umbilical cord blood and tissue. Its operations span Germany, Spain, and global markets. The company actively develops a range of adv...